• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆管腺纤维瘤与恶性转化风险

Biliary Adenofibroma and the Threat of Malignant Transformation.

作者信息

Youssef Mohamed A, Gosnell Joseph, Stevenson Heather L

机构信息

Division of Nephrology, The University of Texas Medical Branch, Galveston, TX, USA.

Department of Pathology, The University of Texas Medical Branch, Galveston, TX, USA.

出版信息

Int J Surg Pathol. 2025 Oct;33(7):1658-1665. doi: 10.1177/10668969251331176. Epub 2025 Apr 13.

DOI:10.1177/10668969251331176
PMID:40221980
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12405656/
Abstract

Biliary adenofibroma (BAF) is a rare hepatic tumor with a high risk for malignant transformation. Since BAF shares many characteristics with other hepatic lesions, diagnosis usually requires meticulous evaluation. The literature review revealed 29 reported patients of BAF, with malignant transformation occurring in 45% of patients. High Ki-67 (>40%) and mutated/overexpressed p53 staining were associated with malignancy, but some patients also had malignant features with low Ki-67 (≤10%) and wild-type p53. We report an elderly female patient who was initially diagnosed with benign liver hemangioma based on an abdominal ultrasound. The mass enlarged by 4 cm raising concerns about potential complications, including hemorrhage, which led to hepatic segmental resection. Histopathological examination revealed predominantly BAF features with focal areas that showed malignant cholangiocarcinoma characteristics.

摘要

胆管腺纤维瘤(BAF)是一种罕见的肝脏肿瘤,具有较高的恶变风险。由于BAF与其他肝脏病变有许多共同特征,诊断通常需要细致评估。文献回顾显示有29例BAF患者的报道,其中45%的患者发生了恶变。高Ki-67(>40%)以及p53染色突变/过表达与恶性肿瘤相关,但一些患者Ki-67低(≤10%)且p53为野生型时也具有恶性特征。我们报告一名老年女性患者,最初根据腹部超声诊断为良性肝血管瘤。肿块增大了4厘米,引发了对包括出血在内的潜在并发症的担忧,这导致了肝段切除术。组织病理学检查显示主要为BAF特征,局部区域表现出恶性胆管癌特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2e6/12405656/d2e02427a6dc/10.1177_10668969251331176-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2e6/12405656/f04b5173bed7/10.1177_10668969251331176-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2e6/12405656/59d790729ddd/10.1177_10668969251331176-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2e6/12405656/d2e02427a6dc/10.1177_10668969251331176-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2e6/12405656/f04b5173bed7/10.1177_10668969251331176-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2e6/12405656/59d790729ddd/10.1177_10668969251331176-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c2e6/12405656/d2e02427a6dc/10.1177_10668969251331176-fig3.jpg

相似文献

1
Biliary Adenofibroma and the Threat of Malignant Transformation.胆管腺纤维瘤与恶性转化风险
Int J Surg Pathol. 2025 Oct;33(7):1658-1665. doi: 10.1177/10668969251331176. Epub 2025 Apr 13.
2
Biliary pseudo tumor associated with hepatic atrophy.与肝萎缩相关的胆道假性肿瘤。
Hum Pathol. 2025 Sep;163:105879. doi: 10.1016/j.humpath.2025.105879. Epub 2025 Jul 24.
3
Malignant Transformation Arising Within Unusual and Rare Hepatic Lesions: Fibropolycystic Disease Form of Ductal Plate Malformation and Biliary Adenofibroma.罕见及不常见肝脏病变中发生的恶性转化:导管板畸形的纤维多囊疾病形式及胆管腺纤维瘤
Int J Surg Pathol. 2018 Sep;26(6):542-550. doi: 10.1177/1066896918758172. Epub 2018 Feb 21.
4
Characterization of Cholangiocarcinomas With Tubulocystic Morphology Associated With Biliary Adenofibroma or Biliary Adenofibroma-Like Lesions.具有与胆管腺纤维瘤或胆管腺纤维瘤样病变相关的微管囊状形态的胆管癌的特征
Mod Pathol. 2025 Jun 13;38(10):100815. doi: 10.1016/j.modpat.2025.100815.
5
Intrahepatic Cholangiocarcinoma in a Background of Biliary Adenofibroma: A Rare Entity.以胆管腺纤维瘤为背景的肝内胆管癌:一种罕见的实体。
J Gastrointest Cancer. 2023 Dec;54(4):1359-1361. doi: 10.1007/s12029-023-00931-6. Epub 2023 Mar 30.
6
A case of biliary adenofibroma with malignant transformation.一例发生恶性转化的胆管腺纤维瘤。
Pathol Res Pract. 2016 May;212(5):468-70. doi: 10.1016/j.prp.2015.12.015. Epub 2015 Dec 31.
7
Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma.可切除胆管癌的术后辅助化疗。
Cochrane Database Syst Rev. 2021 Sep 13;9(9):CD012814. doi: 10.1002/14651858.CD012814.pub2.
8
Biliary adenofibroma and cholangiocarcinoma: neighbors or relatives? A systematic and critical review.胆管腺纤维瘤与胆管癌:邻居还是亲属?一项系统的批判性综述。
Hum Pathol. 2025 Jul 12:105872. doi: 10.1016/j.humpath.2025.105872.
9
Intrahepatic cholangiocarcinoma developing from biliary hamartomas: A case report and literature review.起源于胆管错构瘤的肝内胆管癌:1例报告及文献复习
Int J Surg Case Rep. 2025 Aug;133:111524. doi: 10.1016/j.ijscr.2025.111524. Epub 2025 Jun 16.
10
PTEN deficiency induces an extrahepatic cholangitis-cholangiocarcinoma continuum via aurora kinase A in mice.PTEN 缺失通过小鼠中的极光激酶 A 诱导肝外胆管炎-胆管癌连续病变。
J Hepatol. 2024 Jul;81(1):120-134. doi: 10.1016/j.jhep.2024.02.018. Epub 2024 Feb 28.

本文引用的文献

1
Tubulocystic Carcinoma of Bile Ducts: A Distinct Type of Cholangiocarcinoma Associated With Adenofibroma-type Lesions.胆管管状囊性癌:一种与腺纤维瘤样病变相关的独特胆管癌类型。
Am J Surg Pathol. 2024 Sep 1;48(9):1082-1092. doi: 10.1097/PAS.0000000000002278. Epub 2024 Jul 1.
2
Biliary adenofibroma: a precursor lesion of intrahepatic cholangiocarcinoma.胆管腺纤维瘤:肝内胆管癌的一种前驱病变。
Autops Case Rep. 2023 Nov 13;13:e2023453. doi: 10.4322/acr.2023.453. eCollection 2023.
3
Flavokawain B Inhibits Growth of Cholangiocarcinoma Cells by Suppressing the Akt Pathway.
flavokawain B 通过抑制 Akt 通路抑制胆管癌细胞生长。
In Vivo. 2023 May-Jun;37(3):1077-1084. doi: 10.21873/invivo.13182.
4
Malignant transformation of biliary adenofibroma combined with benign lymphadenopathy mimicking advanced liver carcinoma: A case report.胆管腺纤维瘤恶变合并良性淋巴结病酷似晚期肝癌:一例报告
World J Clin Cases. 2022 Sep 6;10(25):9104-9111. doi: 10.12998/wjcc.v10.i25.9104.
5
Up-to-Date Pathologic Classification and Molecular Characteristics of Intrahepatic Cholangiocarcinoma.肝内胆管癌的最新病理分类及分子特征
Front Med (Lausanne). 2022 Mar 31;9:857140. doi: 10.3389/fmed.2022.857140. eCollection 2022.
6
Imaging features of biliary adenofibroma of the liver with malignant transformation: a case report with literature review.肝脏腺纤维瘤恶变的影像学特征:1例病例报告并文献复习
BMC Med Imaging. 2022 Mar 17;22(1):47. doi: 10.1186/s12880-022-00775-9.
7
Biliary Adenofibroma: A Rare Liver Tumor with Transition to Invasive Carcinoma.胆管腺纤维瘤:一种罕见的可转变为浸润性癌的肝脏肿瘤。
Case Rep Surg. 2022 Feb 7;2022:5280884. doi: 10.1155/2022/5280884. eCollection 2022.
8
Intrahepatic Cholangiocarcinoma: A Summative Review of Biomarkers and Targeted Therapies.肝内胆管癌:生物标志物与靶向治疗的综述
Cancers (Basel). 2021 Oct 15;13(20):5169. doi: 10.3390/cancers13205169.
9
Application of Immune Checkpoint Inhibitors in the Treatment of Cholangiocarcinoma.免疫检查点抑制剂在胆管癌治疗中的应用。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211039952. doi: 10.1177/15330338211039952.
10
Patterns of Whole Exome Sequencing in Resected Cholangiocarcinoma.切除的胆管癌全外显子组测序模式
Cancers (Basel). 2021 Aug 12;13(16):4062. doi: 10.3390/cancers13164062.